IGFBP2 and lung cancer: To test whether there is a difference in circulating IGFBP2 levels between lung cancer patients and healthy controls, we obtained plasma samples of 80 lung cancer patients and 80 case-matched healthy samples from the blood bank maintained at our institution’s department of epidemiology.